Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Prostate Cancer Debate 2014 /
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer

23rd - 24th Jan 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.01.14
Views: 4599

Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr John Fitzpatrick

Recently, a number of therapies have been approved that provide more treatment options and improve outcomes for men with metastatic castration-resistant prostate cancer (mCRPC). This expert discussion examines the latest developments in hormone therapies and asks what the future may look like for prostate cancer patients.

Discussion includes:

-       State of the art treatment options for patients with mCRPC

-       The role of chemotherapy in the future management of mCRPC

-       Treating mCRPC patients after docetaxel therapy

-       Quality of life measurement

-       Personalised medicine in prostate cancer

With: Dr Cora Sternberg, San Camillo and Forlanini Hospitals, Italy, Dr Marc Rubin, Cornell University, USA, Dr Heather Payne, University College London, UK, Dr Maria De Santis, Kaiser Franz Josef Hospital, Austria and Dr John Fitzpatrick, Irish Cancer Society and University College Dublin, Ireland


This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation